+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Global Clinical In Vitro Diagnostic Medical Laboratory Services Market. Strategies & Trends. Volume & Price. Updated with Impact of COVID-19 Pandemic. Situation Analysis and Executive & Consultant Guides. 2020 to 2024

  • ID: 5018690
  • Report
  • April 2021
  • Region: Global
  • 340 Pages
  • Howe Sound Research

FEATURED COMPANIES

  • ACM Medical Laboratory
  • BP Healthcare Group.
  • Enzo Life Sciences, Inc.
  • Genzyme Corporation
  • Mayo Clinic Laboratories.
  • Quest Diagnostics

The Clinical Laboratory has seen steady growth for the last 20 years, but this is changing with the effect of the COVID pandemic on healthcare and economic activity. Worse still, Point of Care and Self Testing are threatening long term demand. Understand the opportunities and the threats in this comprehensive report.

The fundamentals are still here. Clinical laboratory testing is positioned to directly benefit from the explosion in biotechnology, especially genomics. Learn all about it in this new report from Howe Sound Research. A range of dynamic trends are pushing market growth and company valuations.

Trends like:

  • the genetic blizzard
  • emerging economies and global prosperity
  • pharmacogenomics
  • healthcare expansion in China
  • climate change
  • globalization
  • automation

Exciting technical developments, especially in the area of molecular diagnostics and pharmacogenomics, hold the promise of a dynamic, growing and evolving world market that is moving out of the national and regional orientation and onto a global stage.

The report provides data that analysts and planners can use. Hundreds of pages of information including a complete list of Current 2020 United States Medicare Fee Payment Schedules to help sharpen your pricing. Make facilities planning decisions. Forecast demand for new testing regimes or technologies. Make research investment decisions.

The report includes detailed breakouts for 15 Countries and 4 Regions. A detailed breakout for any country in the world is available to purchasers of the report.

Note: Product cover images may vary from those shown

FEATURED COMPANIES

  • ACM Medical Laboratory
  • BP Healthcare Group.
  • Enzo Life Sciences, Inc.
  • Genzyme Corporation
  • Mayo Clinic Laboratories.
  • Quest Diagnostics

i. Clinical Laboratory Services - Strategic Situation Analysis and Impact Analysis of COVID Recession

ii. Guide for Executives, Marketing, Sales and Business Development Staff

iii. Guide for Management Consultants and Investment Advisors

1. Introduction and Market Definition
1.1 the Growing Demand for Clinical Testing
1.2 Defining the Opportunity
1.2.1 Volumes
1.2.2 Prices
1.2.3 Revenue Market Size
1.3 Methods and Sources
1.3.1 Authors
1.3.2 Sources
1.4 U.S. Medical Market and laboratory Testing - Perspective
1.4.1 U.S. Medicare Expenditures for Laboratory Testing

2. Overview of a Dynamic Market
2.1 Market Players – Roles & Impacts
2.1.1 Supplier/pharmaceutical
2.1.2 Independent lab specialized/esoteric
2.1.3 Independent lab national/regional
2.1.4 Independent lab analytical
2.1.5 Public National/regional lab
2.1.6 Hospital lab
2.1.7 Physician lab
2.1.8 Audit body
2.2 Segmentation – Different Approaches
2.2.1 Traditional Market Segmentation
2.2.2 Laboratory Focus and Segmentation
2.3 Structure of Clinical Testing Industry
2.3.1 the Hospital Lab – Share of the Pie
2.3.2 Key Role for Economies of Scale.
2.3.3 Physician Office Lab’s are Still Here
2.3.4 Physician’s and POCT – Reviving Patient Service in China
2.4 Profiles of Key Companies

  • Acibadem Labmed Laboratory
  • ACM Medical Laboratory
  • Adicon Clinical Laboratories
  • American Bio-Clinical Laboratories, Int'l.
  • American Pathology Partners
  • ARUP Laboratories
  • Ascend Clinical
  • Aurora Diagnostics
  • Bio-Reference Laboratories
  • Bioscientia Institut für Medizinische Diagnostik GmbH
  • BP Healthcare Group.
  • Clinical Reference Laboratory
  • Clongen Laboratories
  • CompuNet Clinical Laboratories
  • Diagnósticos da América
  • DIAN Diagnostics Co., Ltd
  • Enzo Life Sciences, Inc.
  • Eurofins Scientific
  • Exagen Diagnostics.
  • Genomic Health
  • Genzyme Corporation
  • Gribbles Pathology
  • Guangzhou Kingmed Diagnostics Group Co., Ltd
  • Integrated Regional Laboratories
  • KDL Group.
  • Laboratory Corporation of America
  • Lifelabs
  • Mayo Clinic Laboratories.
  • Mid America Clinical Laboratories
  • Myriad Genetics/Myriad RBM
  • NeoGenomics
  • Pathology, Inc.
  • Psychemedics Corporation
  • Quest Diagnostics
  • RDL Reference Laboratory
  • Sonic Healthcare
  • Spectra Laboratories
  • Synlab Group
  • Unilabs

2.5 National and Regional Diversity

3. Trends Driving a Changing Market
3.1 Growth is Pushed from Many Sides
3.1.1 Understanding the Impact of Aging Population.
3.1.2 COVID Related Testing Growth.
3.1.3 Point of Care Testing can increase demand
3.1.4 Alternative Medicine Creates Testing Opportunity
3.1.5 Esoteric Testing Moving Mainstream
3.1.6 Genetic Based Testing Creates New Department and New Discipline
3.2 Factors at Work to Shrink the Market.
3.2.1 COVID 19 Recession.
3.2.2 Economic or population contraction.
3.2.3 Testing usage analysis curtailing growth.
3.2.4 Wellness has a downside
3.2.5 Test Displacement Impacts Important
3.2.6 Point of Care Testing
3.3 Automation
3.3.1 Stranded LIMS Investment
3.3.2 Software as a Service
3.3.3 Physician Office and Access Systems
3.4 Environment and Evolution
3.5 Diagnostic Technology Development
3.5.1 Next Generation Sequencing Fuels a Revolution.
3.5.2 Impact of NGS on pricing
3.5.3 POCT/Self Testing Disruptive Force
3.5.4 Pharmacogenomics Blurs Diagnosis and Treatment
3.5.5 CGES Testing, a Brave New World
3.5.6 Molecular Diagnostics Technologies at the Forefront of Growth
3.5.7 Biochips/Giant magnetoresistance based assay.

4. Laboratory, Molecular Diagnostics and Genomic Testing Recent Developments
4.1 Recent Developments – Importance and How to Use This Section
4.1.1 Importance of These Developments
4.1.2 How to Use This Section

  • Private labs say demand for coronavirus tests is down
  • CDC Ranks Two More Microbes as ‘Urgent Threat’
  • Applied Biology to Launch New Laboratory for Hair and Skin Disorders
  • Quest Diagnostics Acquires Outreach Operations
  • Quest Diagnostics Buys Assets of Boston Clinical Laboratory Services
  • CLA Urges FDA to Halt Crackdown on PGx Testing
  • ACLA Requests $5 billion to keep private labs going
  • Quest Diagnostics Subsidiary Buys True Health Dx Assets
  • BioReference Laboratories selected by IPA Association
  • Predictive Laboratories Announces Research Collaboration
  • NEOMED-LABS / Pacific Biomarkers Acquires PAIRimmune Français
  • LabCorp and Envigo Complete Transactions
  • PathGroup Acquires Pathologists Bio-Medical Laboratories
  • Predictive Technology Acquires Taueret Laboratories
  • Quest Diagnostics Acquires Laboratory Services Business of Boyce & Bynum Pathology
  • Laboratories
  • Gestalt Diagnostics Expands Market Reach with Peak Medical Acquisition
  • Amazon exploring consumer health diagnostics
  • Quest Diagnostics Acquires Laboratory Services Operation in Central Michigan
  • NeoGenomics to acquire Genoptix, Inc.
  • Quest Diagnostics to Acquire U.S. Laboratory Services Business of Oxford Immunotec
  • Charles River Labs to acquire contract research firm for $800M
  • GROUPE BIO7 to be Sold to CERBA HEALTHCARE
  • GE Healthcare and Roche Partner to Develop Digital Diagnostics Platform
  • Digipath Enters into Letter of Intent to Acquire Clinical Lab Companies
  • PSP to acquire European medical lab services company
  • Mars, Incorporated to Acquire VCA Inc.
  • Grifols acquires Hologic’s blood screening unit for $1.85bn
  • LabCorp to acquire clinical laboratories from Mount Sinai.
  • PerkinElmer to buy Germany's Euroimmun for about $1.3 billion
  • LabCorp to Acquire Chiltern for Approximately $1.2 Billion in Cash
  • Precipio Diagnostics and Transgenomic Complete Merger
  • $550 Dock Turns a Smartphone into a Medical Lab.
  • LabCorp & Interpace Extend Deal, Boost Cancer Portfolio
  • Quest Diagnostics to Acquire Shiel Medical Laboratory from Fresenius Medical Care
  • Quest Diagnostics to Acquire MedXM
  • Overview of Clinical Diagnostic Acquisition Activity
  • New Sysmex Device Provides Blood Test Results at Point of Care in Minutes
  • FDA, Congress Return Attention to Direct-to-Consumer Genetic Testing
  • QIAGEN Enters into Agreement to Acquire STAT-Dx.

5. Country Market Sizes – North America 2016 to 2024
5.1 United States of America 2016 to 2024
5.1.1 Clinical Chemistry – Volumes, Prices, Revenues
5.1.2 Microbiology – Volumes, Prices, Revenues
5.1.3 Hematology – Volumes, Prices, Revenues
5.1.4 Anatomic Pathology – Volumes, Prices, Revenues
5.1.5 Molecular Diagnostics – Volumes, Prices, Revenues
5.1.6 All Clinical Testing – Volumes, Prices, Revenues
5.1.7 Esoteric – Volumes, Prices, Revenues
5.2 Canada 2016 to 2024
5.2.1 Clinical Chemistry – Volumes, Prices, Revenues
5.2.2 Microbiology – Volumes, Prices, Revenues
5.2.3 Hematology – Volumes, Prices, Revenues
5.2.4 Anatomic Pathology – Volumes, Prices, Revenues 168
5.2.5 Molecular Diagnostics – Volumes, Prices, Revenues
5.2.6 All Clinical Testing – Volumes, Prices, Revenues
5.2.7 Esoteric – Volumes, Prices, Revenues

6. Country Markets – Europe 2016 to 2024
6.1 France 2016 to 2024
6.1.1 Clinical Chemistry – Volumes, Prices, Revenues
6.1.2 Microbiology – Volumes, Prices, Revenues
6.1.3 Hematology – Volumes, Prices, Revenues
6.1.4 Anatomic Pathology – Volumes, Prices, Revenues
6.1.5 Molecular Diagnostics – Volumes, Prices, Revenues
6.1.6 All Clinical Testing – Volumes, Prices, Revenues
6.1.7 Esoteric – Volumes, Prices, Revenues
6.2 Germany 2016 to 2024
6.2.1 Clinical Chemistry – Volumes, Prices, Revenues
6.2.2 Microbiology – Volumes, Prices, Revenues
6.2.3 Hematology – Volumes, Prices, Revenues
6.2.4 Anatomic Pathology – Volumes, Prices, Revenues
6.2.5 Molecular Diagnostics – Volumes, Prices, Revenues
6.2.6 All Clinical Testing – Volumes, Prices, Revenues
6.2.7 Esoteric – Volumes, Prices, Revenues
6.3 United Kingdom 2016 to 2024
6.3.1 Clinical Chemistry – Volumes, Prices, Revenues
6.3.2 Microbiology – Volumes, Prices, Revenues
6.3.3 Hematology – Volumes, Prices, Revenues
6.3.4 Anatomic Pathology – Volumes, Prices, Revenues
6.3.5 Molecular Diagnostics – Volumes, Prices, Revenues
6.3.6 All Clinical Testing – Volumes, Prices, Revenues
6.3.7 Esoteric – Volumes, Prices, Revenues
6.4 Spain 2016 to 2024.
6.4.1 Clinical Chemistry – Volumes, Prices, Revenues
6.4.2 Microbiology – Volumes, Prices, Revenues
6.4.3 Hematology – Volumes, Prices, Revenues
6.4.4 Anatomic Pathology – Volumes, Prices, Revenues
6.4.5 Molecular Diagnostics – Volumes, Prices, Revenues
6.4.6 All Clinical Testing – Volumes, Prices, Revenues
6.4.7 Esoteric – Volumes, Prices, Revenues
6.5 Italy 2016 to 2024
6.5.1 Clinical Chemistry – Volumes, Prices, Revenues
6.5.2 Microbiology – Volumes, Prices, Revenues
6.5.3 Hematology – Volumes, Prices, Revenues
6.5.4 Anatomic Pathology – Volumes, Prices, Revenues
6.5.5 Molecular Diagnostics – Volumes, Prices, Revenues
6.5.6 All Clinical Testing – Volumes, Prices, Revenues
6.5.7 Esoteric – Volumes, Prices, Revenues
6.6 Russia 2016 to 2024
6.6.1 Clinical Chemistry – Volumes, Prices, Revenues
6.6.2 Microbiology – Volumes, Prices, Revenues
6.6.3 Hematology – Volumes, Prices, Revenues
6.6.4 Anatomic Pathology – Volumes, Prices, Revenues
6.6.5 Molecular Diagnostics – Volumes, Prices, Revenues
6.6.6 All Clinical Testing – Volumes, Prices, Revenues
6.6.7 Esoteric – Volumes, Prices, Revenues
6.7 Remainder of Europe and Former Soviet Union 2016 to 2024.
6.7.1 Clinical Chemistry – Volumes, Prices, Revenues
6.7.2 Microbiology – Volumes, Prices, Revenues
6.7.3 Hematology – Volumes, Prices, Revenues
6.7.4 Anatomic Pathology – Volumes, Prices, Revenues
6.7.5 Molecular Diagnostics – Volumes, Prices, Revenues
6.7.6 All Clinical Testing – Volumes, Prices, Revenues
6.7.7 Esoteric – Volumes, Prices, Revenues

7. Country Markets – Asia Pacific 2016 to 2024
7.1 China 2016 to 2024
7.1.1 Clinical Chemistry – Volumes, Prices, Revenues
7.1.2 Microbiology – Volumes, Prices, Revenues
7.1.3 Hematology – Volumes, Prices, Revenues
7.1.4 Anatomic Pathology – Volumes, Prices, Revenues
7.1.5 Molecular Diagnostics – Volumes, Prices, Revenues
7.1.6 All Clinical Testing – Volumes, Prices, Revenues
7.1.7 Esoteric – Volumes, Prices, Revenues
7.2 Japan 2016 to 2024
7.2.1 Clinical Chemistry – Volumes, Prices, Revenues
7.2.2 Microbiology – Volumes, Prices, Revenues
7.2.3 Hematology – Volumes, Prices, Revenues
7.2.4 Anatomic Pathology – Volumes, Prices, Revenues
7.2.5 Molecular Diagnostics – Volumes, Prices, Revenues
7.2.6 All Clinical Testing – Volumes, Prices, Revenues
7.2.7 Esoteric – Volumes, Prices, Revenues
7.3 South Korea 2016 to 2024
7.3.1 Clinical Chemistry – Volumes, Prices, Revenues
7.3.2 Microbiology – Volumes, Prices, Revenues
7.3.3 Hematology – Volumes, Prices, Revenues . 210
7.3.4 Anatomic Pathology – Volumes, Prices, Revenues
7.3.5 Molecular Diagnostics – Volumes, Prices, Revenues
7.3.6 All Clinical Testing – Volumes, Prices, Revenues
7.3.7 Esoteric – Volumes, Prices, Revenues
7.4 India 2016 to 2024
7.4.1 Clinical Chemistry – Volumes, Prices, Revenues
7.4.2 Microbiology – Volumes, Prices, Revenues
7.4.3 Hematology – Volumes, Prices, Revenues
7.4.4 Anatomic Pathology – Volumes, Prices, Revenues
7.4.5 Molecular Diagnostics – Volumes, Prices, Revenues
7.14.6 All Clinical Testing – Volumes, Prices, Revenues
7.4.7 Esoteric – Volumes, Prices, Revenues
7.5 Australia 2016 to 2024
7.5.1 Clinical Chemistry – Volumes, Prices, Revenues
7.5.2 Microbiology – Volumes, Prices, Revenues
7.5.3 Hematology – Volumes, Prices, Revenues
7.5.4 Anatomic Pathology – Volumes, Prices, Revenues
7.5.5 Molecular Diagnostics – Volumes, Prices, Revenues
7.5.6 All Clinical Testing – Volumes, Prices, Revenues
7.5.7 Esoteric – Volumes, Prices, Revenues
7.6 Rest of Asia Pacific 2016 to 2024
7.6.1 Clinical Chemistry – Volumes, Prices, Revenues
7.6.2 Microbiology – Volumes, Prices, Revenues
7.6.3 Hematology – Volumes, Prices, Revenues
7.6.4 Anatomic Pathology – Volumes, Prices, Revenues
7.6.5 Molecular Diagnostics – Volumes, Prices, Revenues
7.6.6 All Clinical Testing – Volumes, Prices, Revenues
7.6.7 Esoteric – Volumes, Prices, Revenues

8. Country Markets – Latin America, Africa & the Middle East 2016 to 2024.
8.1 Brazil 2016 to 2024
8.1.1 Clinical Chemistry – Volumes, Prices, Revenues
8.1.2 Microbiology – Volumes, Prices, Revenues
8.1.3 Hematology – Volumes, Prices, Revenues
8.1.4 Anatomic Pathology – Volumes, Prices, Revenues
8.1.5 Molecular Diagnostics – Volumes, Prices, Revenues
8.1.6 All Clinical Testing – Volumes, Prices, Revenues
8.1.7 Esoteric – Volumes, Prices, Revenues
8.2 Mexico 2016 to 2024.
8.2.1 Clinical Chemistry – Volumes, Prices, Revenues
8.2.2 Microbiology – Volumes, Prices, Revenues
8.2.3 Hematology – Volumes, Prices, Revenues
8.2.4 Anatomic Pathology – Volumes, Prices, Revenues
8.2.5 Molecular Diagnostics – Volumes, Prices, Revenues
8.2.6 All Clinical Testing – Volumes, Prices, Revenues
8.2.7 Esoteric – Volumes, Prices, Revenues
8.3 Remainder of Latin America 2016 to 2024
8.3.1 Clinical Chemistry – Volumes, Prices, Revenues
8.3.2 Microbiology – Volumes, Prices, Revenues
8.3.3 Hematology – Volumes, Prices, Revenues
8.3.4 Anatomic Pathology – Volumes, Prices, Revenues
8.3.5 Molecular Diagnostics – Volumes, Prices, Revenues
8.3.6 All Clinical Testing – Volumes, Prices, Revenues
8.3.7 Esoteric – Volumes, Prices, Revenues
8.4 Africa & the Middle East 2016 to 2024 238
8.4.1 Clinical Chemistry – Volumes, Prices, Revenues
8.4.2 Microbiology – Volumes, Prices, Revenues
8.4.3 Hematology – Volumes, Prices, Revenues
8.4.4 Anatomic Pathology – Volumes, Prices, Revenues
8.4.5 Molecular Diagnostics – Volumes, Prices, Revenues
8.4.6 All Clinical Testing – Volumes, Prices, Revenues
8.4.7 Esoteric – Volumes, Prices, Revenues

9. Global Market Summary 2016 to 2024
9.1 Global Market 2016 to 2024.
9.1.1 Clinical Chemistry – Volumes, Prices, Revenues
9.1.2 Microbiology – Volumes, Prices, Revenues
9.1.3 Hematology – Volumes, Prices, Revenues
9.1.4 Anatomic Pathology – Volumes, Prices, Revenues
9.1.5 Molecular Diagnostics – Volumes, Prices, Revenues
9.1.6 All Clinical Testing – Volumes, Prices, Revenues
9.1.7 Esoteric – Volumes, Prices, Revenues

10. the Future of the Clinical Laboratory

11. Additional Country Breakouts McKinsey
11.1 Switzerland 2016 to 2024 .
11.1.1 Clinical Chemistry – Volumes, Prices, Revenues
11.1.2 Microbiology – Volumes, Prices, Revenues
11.1.3 Hematology – Volumes, Prices, Revenues
11.1.4 Anatomic Pathology – Volumes, Prices, Revenues
11.1.5 Molecular Diagnostics – Volumes, Prices, Revenues
11.1.6 All Clinical Testing – Volumes, Prices, Revenues
11.1.7 Esoteric – Volumes, Prices, Revenues
11.2 Portugal 2016 to 2024
11.2.1 Clinical Chemistry – Volumes, Prices, Revenues
11.2.2 Microbiology – Volumes, Prices, Revenues
11.2.3 Hematology – Volumes, Prices, Revenues
11.2.4 Anatomic Pathology – Volumes, Prices, Revenues
11.2.5 Molecular Diagnostics – Volumes, Prices, Revenues
11.2.6 All Clinical Testing – Volumes, Prices, Revenues
11.2.7 Esoteric – Volumes, Prices, Revenues
11.3 Norway 2016 to 2024
11.3.1 Clinical Chemistry – Volumes, Prices, Revenues
11.3.2 Microbiology – Volumes, Prices, Revenues
11.3.3 Hematology – Volumes, Prices, Revenues
11.3.4 Anatomic Pathology – Volumes, Prices, Revenues
11.3.5 Molecular Diagnostics – Volumes, Prices, Revenues
11.3.6 All Clinical Testing – Volumes, Prices, Revenues
11.3.7 Esoteric – Volumes, Prices, Revenues
11.4 Sweden 2016 to 2024
11.4.1 Clinical Chemistry – Volumes, Prices, Revenues
11.4.2 Microbiology – Volumes, Prices, Revenues
11.4.3 Hematology – Volumes, Prices, Revenues
11.4.4 Anatomic Pathology – Volumes, Prices, Revenues
11.4.5 Molecular Diagnostics – Volumes, Prices, Revenues
11.4.6 All Clinical Testing – Volumes, Prices, Revenues
11.4.7 Esoteric – Volumes, Prices, Revenues
11.5 Benelux 2016 to 2024
11.5.1 Clinical Chemistry – Volumes, Prices, Revenues
11.5.2 Microbiology – Volumes, Prices, Revenues
11.5.3 Hematology – Volumes, Prices, Revenues
11.5.4 Anatomic Pathology – Volumes, Prices, Revenues
11.5.5 Molecular Diagnostics – Volumes, Prices, Revenues
11.5.6 All Clinical Testing – Volumes, Prices, Revenues
11.5.7 Esoteric – Volumes, Prices, Revenues

Appendices
I. United States Medicare System: January 2019 Clinical Laboratory Fees Schedule

List of Tables

Table 1 Lab Spending 2014 to 2024
Table 2 Market Players by Type
Table 3 Clinical Laboratory Departments and Segments
Table 4 Laboratory Management Focus – Different Approaches
Table 5 Key Segmentation Variables Going Forward.
Table 6 Factors Affecting Local Clinical Testing Demand
Table 7 Seven Factors Driving Growth
Table 8 Alternative Medicine Creates New Clinical Testing Markets
Table 9 Six Factors Limiting Growth
Table 10 Key Diagnostic Laboratory Technology Trends
Table 11 Next Generation Sequencing Technologies – Speed and Cost
Table 12 Key Point of Care Testing Uses
Table 13 Clinical Application Areas for Molecular Diagnostics
Table 14 Clinical Chemistry - Volume Price and Revenue Forecast
Table 15 Microbiology - Volume Price and Revenue Forecast
Table 16 Hematology - Volume Price and Revenue Forecast
Table 17 Anatomic Pathology - Volume Price and Revenue Forecast
Table 18 Molecular Diagnostics - Volume Price and Revenue Forecast
Table 19 All Clinical Testing - Volume Price and Revenue Forecast
Table 20 Esoteric - Volume Price and Revenue Forecast
Table 21 Clinical Chemistry - Volume Price and Revenue Forecast
Table 22 Microbiology - Volume Price and Revenue Forecast
Table 23 Hematology - Volume Price and Revenue Forecast
Table 24 Anatomic Pathology - Volume Price and Revenue Forecast
Table 25 Molecular Diagnostics - Volume Price and Revenue Forecast
Table 26 All Clinical Testing - Volume Price and Revenue Forecast
Table 27 Esoteric - Volume Price and Revenue Forecast
Table 28 Clinical Chemistry - Volume Price and Revenue Forecast
Table 29 Microbiology - Volume Price and Revenue Forecast
Table 30 Hematology - Volume Price and Revenue Forecast
Table 31 Anatomic Pathology - Volume Price and Revenue Forecast
Table 32 Molecular Diagnostics - Volume Price and Revenue Forecast
Table 33 All Clinical Testing - Volume Price and Revenue Forecast
Table 34 Esoteric - Volume Price and Revenue Forecast
Table 35 Clinical Chemistry - Volume Price and Revenue Forecast
Table 36 Microbiology - Volume Price and Revenue Forecast
Table 37 Hematology - Volume Price and Revenue Forecast
Table 38 Anatomic Pathology - Volume Price and Revenue Forecast
Table 39 Molecular Diagnostics - Volume Price and Revenue Forecast
Table 40 All Clinical Testing - Volume Price and Revenue Forecast
Table 41 Esoteric - Volume Price and Revenue Forecast
Table 42 Clinical Chemistry - Volume Price and Revenue Forecast
Table 43 Microbiology - Volume Price and Revenue Forecast
Table 44 Hematology - Volume Price and Revenue Forecast
Table 45 Anatomic Pathology - Volume Price and Revenue Forecast
Table 46 Molecular Diagnostics - Volume Price and Revenue Forecast
Table 47 All Clinical Testing - Volume Price and Revenue Forecast
Table 48 Esoteric - Volume Price and Revenue Forecast
Table 49 Clinical Chemistry - Volume Price and Revenue Forecast
Table 50 Microbiology - Volume Price and Revenue Forecast
Table 51 Hematology - Volume Price and Revenue Forecast
Table 52 Anatomic Pathology - Volume Price and Revenue Forecast
Table 53 Molecular Diagnostics - Volume Price and Revenue Forecast
Table 54 All Clinical Testing - Volume Price and Revenue Forecast
Table 55 Esoteric - Volume Price and Revenue Forecast
Table 56 Clinical Chemistry - Volume Price and Revenue Forecast
Table 57 Microbiology - Volume Price and Revenue Forecast
Table 58 Hematology - Volume Price and Revenue Forecast
Table 59 Anatomic Pathology - Volume Price and Revenue Forecast
Table 60 Molecular Diagnostics - Volume Price and Revenue Forecast
Table 61 All Clinical Testing - Volume Price and Revenue Forecast
Table 62 Esoteric - Volume Price and Revenue Forecast
Table 63 Clinical Chemistry - Volume Price and Revenue Forecast
Table 64 Microbiology - Volume Price and Revenue Forecast
Table 65 Hematology - Volume Price and Revenue Forecast
Table 66 Anatomic Pathology - Volume Price and Revenue Forecast
Table 67 Molecular Diagnostics - Volume Price and Revenue Forecast
Table 68 All Clinical Testing - Volume Price and Revenue Forecast
Table 69 Esoteric - Volume Price and Revenue Forecast
Table 70 Clinical Chemistry - Volume Price and Revenue Forecast
Table 71 Microbiology - Volume Price and Revenue Forecast
Table 72 Hematology - Volume Price and Revenue Forecast
Table 73 Anatomic Pathology - Volume Price and Revenue Forecast
Table 74 Molecular Diagnostics - Volume Price and Revenue Forecast
Table 75 All Clinical Testing - Volume Price and Revenue Forecast
Table 76 Esoteric - Volume Price and Revenue Forecast
Table 77 Clinical Chemistry - Volume Price and Revenue Forecast
Table 78 Microbiology - Volume Price and Revenue Forecast
Table 79 Hematology - Volume Price and Revenue Forecast
Table 80 Anatomic Pathology - Volume Price and Revenue Forecast
Table 81 Molecular Diagnostics - Volume Price and Revenue Forecast
Table 82 All Clinical Testing - Volume Price and Revenue Forecast
Table 83 Esoteric - Volume Price and Revenue Forecast
Table 84 Clinical Chemistry - Volume Price and Revenue Forecast
Table 85 Microbiology - Volume Price and Revenue Forecast
Table 86 Hematology - Volume Price and Revenue Forecast
Table 87 Anatomic Pathology - Volume Price and Revenue Forecast
Table 88 Molecular Diagnostics - Volume Price and Revenue Forecast
Table 89 All Clinical Testing - Volume Price and Revenue Forecast
Table 90 Esoteric - Volume Price and Revenue Forecast
Table 91 Clinical Chemistry - Volume Price and Revenue Forecast
Table 92 Microbiology - Volume Price and Revenue Forecast
Table 93 Hematology - Volume Price and Revenue Forecast
Table 94 Anatomic Pathology - Volume Price and Revenue Forecast
Table 95 Molecular Diagnostics - Volume Price and Revenue Forecast
Table 96 All Clinical Testing - Volume Price and Revenue Forecast
Table 97 Esoteric - Volume Price and Revenue Forecast212
Table 98 Clinical Chemistry - Volume Price and Revenue Forecast
Table 99 Microbiology - Volume Price and Revenue Forecast
Table 100 Hematology - Volume Price and Revenue Forecast
Table 101 Anatomic Pathology - Volume Price and Revenue Forecast
Table 102 Molecular Diagnostics - Volume Price and Revenue Forecast
Table 103 All Clinical Testing - Volume Price and Revenue Forecast.
Table 104 Esoteric - Volume Price and Revenue Forecast
Table 105 Clinical Chemistry - Volume Price and Revenue Forecast
Table 106 Microbiology - Volume Price and Revenue Forecast
Table 107 Hematology - Volume Price and Revenue Forecast
Table 108 Anatomic Pathology - Volume Price and Revenue Forecast .
Table 109 Molecular Diagnostics - Volume Price and Revenue Forecast
Table 110 All Clinical Testing - Volume Price and Revenue Forecast.
Table 111 Esoteric - Volume Price and Revenue Forecast
Table 112 Clinical Chemistry - Volume Price and Revenue Forecast
Table 113 Microbiology - Volume Price and Revenue Forecast
Table 114 Hematology - Volume Price and Revenue Forecast
Table 115 Anatomic Pathology - Volume Price and Revenue Forecast
Table 116 Molecular Diagnostics - Volume Price and Revenue Forecast
Table 117 All Clinical Testing - Volume Price and Revenue Forecast.
Table 118 Esoteric - Volume Price and Revenue Forecast
Table 119 Clinical Chemistry - Volume Price and Revenue Forecast
Table 120 Microbiology - Volume Price and Revenue Forecast
Table 121 Hematology - Volume Price and Revenue Forecast
Table 122 Anatomic Pathology - Volume Price and Revenue Forecast
Table 123 Molecular Diagnostics - Volume Price and Revenue Forecast
Table 124 All Clinical Testing - Volume Price and Revenue Forecast.
Table 125 Esoteric - Volume Price and Revenue Forecast
Table 126 Clinical Chemistry - Volume Price and Revenue Forecast
Table 127 Microbiology - Volume Price and Revenue Forecast
Table 128 Hematology - Volume Price and Revenue Forecast
Table 129 Anatomic Pathology - Volume Price and Revenue Forecast
Table 130 Molecular Diagnostics - Volume Price and Revenue Forecast
Table 131 All Clinical Testing - Volume Price and Revenue Forecast.
Table 132 Esoteric - Volume Price and Revenue Forecast
Table 133 Clinical Chemistry - Volume Price and Revenue Forecast
Table 134 Microbiology - Volume Price and Revenue Forecast
Table 135 Hematology - Volume Price and Revenue Forecast
Table 136 Anatomic Pathology - Volume Price and Revenue Forecast
Table 137 Molecular Diagnostics - Volume Price and Revenue Forecast
Table 138 All Clinical Testing - Volume Price and Revenue Forecast.
Table 139 Esoteric - Volume Price and Revenue Forecast
Table 140 Clinical Chemistry - Volume Price and Revenue Forecast
Table 141 Microbiology - Volume Price and Revenue Forecast
Table 142 Hematology - Volume Price and Revenue Forecast
Table 143 Anatomic Pathology - Volume Price and Revenue Forecast
Table 144 Molecular Diagnostics - Volume Price and Revenue Forecast
Table 145 All Clinical Testing - Volume Price and Revenue Forecast.
Table 146 Esoteric - Volume Price and Revenue Forecast
Table 147 Clinical Chemistry - Volume Price and Revenue Forecast
Table 148 Microbiology - Volume Price and Revenue Forecast
Table 149 Hematology - Volume Price and Revenue Forecast
Table 150 Anatomic Pathology - Volume Price and Revenue Forecast
Table 151 Molecular Diagnostics - Volume Price and Revenue Forecast
Table 152 All Clinical Testing - Volume Price and Revenue Forecast.
Table 153 Esoteric - Volume Price and Revenue Forecast
Table 154 Clinical Chemistry - Volume Price And Revenue Forecast .
Table 155 Microbiology - Volume Price And Revenue Forecast
Table 156 Hematology - Volume Price And Revenue Forecast
Table 157 Anatomic Pathology - Volume Price And Revenue Forecast
Table 158 Molecular Diagnostics - Volume Price And Revenue Forecast
Table 159 All Clinical Testing - Volume Price And Revenue Forecast
Table 160 Esoteric - Volume Price And Revenue Forecast
Table 161 Clinical Chemistry - Volume Price And Revenue Forecast
Table 162 Microbiology - Volume Price And Revenue Forecast
Table 163 Hematology - Volume Price And Revenue Forecast
Table 164 Anatomic Pathology - Volume Price And Revenue Forecast
Table 165 Molecular Diagnostics - Volume Price And Revenue Forecast
Table 166 All Clinical Testing - Volume Price And Revenue Forecast
Table 167 Esoteric - Volume Price And Revenue Forecast
Table 168 Clinical Chemistry - Volume Price And Revenue Forecast
Table 169 Microbiology - Volume Price And Revenue Forecast
Table 170 Hematology - Volume Price And Revenue Forecast
Table 171 Anatomic Pathology - Volume Price And Revenue Forecast
Table 172 Molecular Diagnostics - Volume Price And Revenue Forecast
Table 173 All Clinical Testing - Volume Price And Revenue Forecast
Table 174 Esoteric - Volume Price And Revenue Forecast
Table 175 Clinical Chemistry - Volume Price And Revenue Forecast
Table 176 Microbiology - Volume Price And Revenue Forecast
Table 177 Hematology - Volume Price And Revenue Forecast
Table 178 Anatomic Pathology - Volume Price And Revenue Forecast
Table 179 Molecular Diagnostics - Volume Price And Revenue Forecast
Table 180 All Clinical Testing - Volume Price And Revenue Forecast
Table 181 Esoteric - Volume Price And Revenue Forecast
Table 182 Clinical Chemistry - Volume Price and Revenue Forecast
Table 183 Microbiology - Volume Price and Revenue Forecast
Table 184 Hematology - Volume Price and Revenue Forecast
Table 185 Anatomic Pathology - Volume Price and Revenue Forecast
Table 186 Molecular Diagnostics - Volume Price and Revenue Forecast
Table 187 All Clinical Testing - Volume Price and Revenue Forecast.
Table 188 Esoteric - Volume Price and Revenue Forecast
Table 189 2019 Clinical Lab Fee Schedule

List of Figures

Figure 1 Clinical Lab Spending 2014 to 2024

Note: Product cover images may vary from those shown
  • Acibadem Labmed Laboratory
  • ACM Medical Laboratory
  • Adicon Clinical Laboratories
  • American Bio-Clinical Laboratories, Int'l.
  • American Pathology Partners
  • ARUP Laboratories
  • Ascend Clinical
  • Aurora Diagnostics
  • Bio-Reference Laboratories
  • Bioscientia Institut für Medizinische Diagnostik GmbH
  • BP Healthcare Group.
  • Clinical Reference Laboratory
  • Clongen Laboratories
  • CompuNet Clinical Laboratories
  • Diagnósticos da América
  • DIAN Diagnostics Co., Ltd
  • Enzo Life Sciences, Inc.
  • Eurofins Scientific
  • Exagen Diagnostics.
  • Genomic Health
  • Genzyme Corporation
  • Gribbles Pathology
  • Guangzhou Kingmed Diagnostics Group Co., Ltd
  • Integrated Regional Laboratories
  • KDL Group.
  • Laboratory Corporation of America
  • Lifelabs
  • Mayo Clinic Laboratories.
  • Mid America Clinical Laboratories
  • Myriad Genetics/Myriad RBM
  • NeoGenomics
  • Pathology, Inc.
  • Psychemedics Corporation
  • Quest Diagnostics
  • RDL Reference Laboratory
  • Sonic Healthcare
  • Spectra Laboratories
  • Synlab Group
  • Unilabs
Note: Product cover images may vary from those shown
Adroll
adroll